The role of cellular senescence in cardiovascular disease
Chengying Xu1, Zhimei Qiu1, Qing Guo1
1Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Insights
Cellular senescence, a hallmark of aging, significantly contributes to cardiovascular diseases. Targeting senescent cells offers a promising strategy to prevent and treat age-related heart conditions.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Cell Biology
Background:
- Cardiovascular diseases (CVDs) are a leading cause of death, with incidence increasing with age.
- Cellular senescence, a state of irreversible cell cycle arrest, is a key driver of aging and a risk factor for various CVDs.
- Senescence contributes to hypertension, atherosclerosis, myocardial infarction, heart failure, and arrhythmia.
Purpose of the Study:
- To comprehensively review the regulatory mechanisms of cellular senescence.
- To elucidate the role of cellular senescence in the initiation and progression of cardiovascular diseases.
- To explore targeted interventions for cellular senescence in CVDs.
Main Methods:
- Literature review of cellular senescence and cardiovascular disease mechanisms.
- Analysis of the implications of senescence on CVD development.
- Evaluation of senolytic and senostatic therapeutic strategies.
Main Results:
- Cellular senescence is intricately linked to the pathogenesis of major cardiovascular diseases.
- Accumulation of senescent cells exacerbates cardiovascular dysfunction.
- Targeting senescent cells demonstrates potential for mitigating CVDs.
Conclusions:
- Understanding senescence mechanisms is crucial for developing novel CVD prevention and treatment strategies.
- Eliminating or inhibiting senescent cells may reduce the burden of age-related cardiovascular diseases.
- Further research into senescence regulation holds promise for improving cardiovascular health in aging populations.
Abstract:
The incidence of cardiovascular diseases rises significantly with age, making it one of the leading causes of death and disability worldwide, and cellular senescence plays a crucial role in this process. Cellular senescence constitutes a salient feature of organismal aging and stands as an independent risk factor for a range of cardiovascular diseases, encompassing hypertension, atherosclerosis, myocardial infarction, heart failure, and arrhythmia. This comprehensive review endeavors to comprehensively delineate the intricate regulatory mechanisms underlying cellular senescence and its attendant biological implications, while elucidating the profound implications of this process on the initiation and progression of cardiovascular diseases. Finally, we will delve into a spectrum of targeted interventions aimed at cellular senescence, specifically focusing on eliminating the accumulation of senescent cells during disease progression or inhibiting the inherent cellular senescence processes. Our ultimate goal is to mitigate or postpone the onset of diseases that are intricately linked to cellular senescence. A profound comprehension and rigorous investigation into the regulatory mechanisms of cellular senescence and their intricate interrelationships hold significant potential to furnish invaluable scientific evidence for the prevention and therapeutic strategies against cardiovascular diseases.
Related Concept Videos
Replicative Cell Senescence
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The Effect of Aging on Tissues
Coronary Artery Disease II: Pathophysiology
Mitochondria


